Irlab Therapeutics Ab Stock Filter Stocks by Fundamentals
IRLAB-A Stock | SEK 3.35 0.16 4.56% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess IRLAB Therapeutics' long-term financial health and intrinsic value.
IRLAB |
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
IRLAB Fundamentals
Return On Equity | -0.28 | |||
Return On Asset | -0.15 | |||
Profit Margin | (1.69) % | |||
Operating Margin | (1.68) % | |||
Current Valuation | 1.74 B | |||
Shares Outstanding | 51.79 M | |||
Shares Owned By Insiders | 38.63 % | |||
Shares Owned By Institutions | 22.49 % | |||
Price To Book | 6.24 X | |||
Price To Sales | 33.49 X | |||
Revenue | 207.78 M | |||
Gross Profit | 126.05 M | |||
EBITDA | 55.62 M | |||
Net Income | 51.78 M | |||
Cash And Equivalents | 401.9 M | |||
Cash Per Share | 2.89 X | |||
Total Debt | 3.57 M | |||
Debt To Equity | 2.90 % | |||
Current Ratio | 9.19 X | |||
Book Value Per Share | 6.25 X | |||
Cash Flow From Operations | 128.64 M | |||
Earnings Per Share | 0.81 X | |||
Target Price | 200.0 | |||
Number Of Employees | 31 | |||
Beta | 0.16 | |||
Market Capitalization | 525.71 M | |||
Total Asset | 472.45 M | |||
Z Score | 88.2 | |||
Net Asset | 472.45 M |
About IRLAB Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IRLAB Therapeutics AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IRLAB Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IRLAB Therapeutics AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in IRLAB Stock
IRLAB Therapeutics financial ratios help investors to determine whether IRLAB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRLAB with respect to the benefits of owning IRLAB Therapeutics security.